Total Payments
$42,724
2024 Payments
$9,309
Companies
58
Transactions
1,234
Medicare Patients
3,606
Medicare Billing
$400,560
Payment Breakdown by Category
Food & Beverage$21,969 (51.4%)
Other$20,400 (47.7%)
Education$354.97 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,969 | 1,215 | 51.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,200 | 4 | 26.2% |
| Honoraria | $9,200 | 3 | 21.5% |
| Education | $354.97 | 8 | 0.8% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$42,724
1,230 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| QOL Medical, LLC | $21,962 | 69 | $0 (2024) |
| ABBVIE INC. | $5,197 | 299 | $0 (2024) |
| Janssen Biotech, Inc. | $1,897 | 110 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,707 | 111 | $0 (2024) |
| Gilead Sciences, Inc. | $1,416 | 60 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,269 | 91 | $0 (2024) |
| Celgene Corporation | $1,189 | 69 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $695.61 | 31 | $0 (2024) |
| PFIZER INC. | $610.14 | 34 | $0 (2024) |
| Romark Laboratories, LC | $560.97 | 38 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,309 | 208 | QOL Medical, LLC ($5,960) |
| 2023 | $7,315 | 194 | QOL Medical, LLC ($3,827) |
| 2022 | $5,107 | 165 | QOL Medical, LLC ($2,275) |
| 2021 | $10,417 | 163 | QOL Medical, LLC ($7,506) |
| 2020 | $3,648 | 89 | QOL Medical, LLC ($2,179) |
| 2019 | $1,878 | 105 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($388.87) |
| 2018 | $2,940 | 166 | AbbVie, Inc. ($632.13) |
| 2017 | $2,110 | 144 | AbbVie, Inc. ($662.24) |
All Payment Transactions
1,234 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Gastroenterology | ||||||
| 12/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $18.55 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Immunology | ||||||
| 12/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $115.40 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 833 | 1,116 | $442,279 | $102,989 |
| 2022 | 14 | 779 | 895 | $362,813 | $86,337 |
| 2021 | 20 | 1,039 | 1,449 | $350,227 | $111,077 |
| 2020 | 18 | 955 | 1,359 | $322,002 | $100,157 |
Total Patients
3,606
Total Services
4,819
Medicare Billing
$400,560
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 87 | 89 | $94,963 | $18,095 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 177 | $38,409 | $16,428 | 42.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 71 | 72 | $56,016 | $12,691 | 22.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 83 | 85 | $71,995 | $9,860 | 13.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 94 | 94 | $58,374 | $8,708 | 14.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 131 | $19,388 | $8,250 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $19,256 | $7,206 | 37.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 19 | 150 | $22,800 | $5,393 | 23.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 55 | 55 | $12,045 | $4,191 | 34.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 19 | 85 | $8,500 | $4,072 | 47.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 15 | 16 | $12,496 | $2,777 | 22.2% |
| 43450 | Dilation of esophagus | Facility | 2023 | 58 | 58 | $19,372 | $1,797 | 9.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $3,809 | $1,610 | 42.3% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 11 | 19 | $2,812 | $1,155 | 41.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 14 | $2,044 | $757.64 | 37.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 80 | 81 | $82,167 | $16,388 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 164 | $33,725 | $13,997 | 41.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 58 | 58 | $43,878 | $10,589 | 24.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 101 | 104 | $58,046 | $9,588 | 16.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 69 | 69 | $55,219 | $7,788 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 114 | $16,522 | $7,669 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $17,745 | $6,454 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $9,276 | $3,441 | 37.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 25 | $6,950 | $2,671 | 38.4% |
| 43450 | Dilation of esophagus | Facility | 2022 | 61 | 61 | $19,326 | $1,904 | 9.9% |
About Dr. Felix Rabito, M.D
Dr. Felix Rabito, M.D is a Gastroenterology healthcare provider based in Covington, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619939410.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Felix Rabito, M.D has received a total of $42,724 in payments from pharmaceutical and medical device companies, with $9,309 received in 2024. These payments were reported across 1,234 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($21,969).
As a Medicare-enrolled provider, Rabito has provided services to 3,606 Medicare beneficiaries, totaling 4,819 services with total Medicare billing of $400,560. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Covington, LA
- Active Since 04/05/2006
- Last Updated 01/12/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1619939410
Products in Payments
- SUCRAID (Drug) $15,741
- Sucraid (Drug) $6,221
- STELARA (Biological) $1,609
- XIFAXAN (Drug) $1,504
- ZEPOSIA (Drug) $1,374
- RINVOQ (Biological) $1,096
- ENTYVIO (Biological) $966.51
- Humira (Biological) $776.64
- SKYRIZI (Biological) $718.72
- HUMIRA (Biological) $657.50
- OCALIVA (Drug) $651.14
- LINZESS (Drug) $553.41
- XELJANZ (Drug) $475.67
- Trulance (Drug) $421.77
- VIBERZI (Drug) $387.41
- DUPIXENT (Biological) $381.83
- REMICADE (Biological) $332.63
- IBSRELA (Drug) $331.85
- TREMFYA (Drug) $273.34
- Alinia Tablets 500mg 30 count bottle (Drug) $267.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Covington
Nathaniel Ranney, M.d, M.D
Gastroenterology — Payments: $349,226
Gastroenterology $349,226
Michael Cheng, M.d, M.D
Gastroenterology — Payments: $21,190
Gastroenterology $21,190
Geoffrey Goldsberry, Do, DO
Gastroenterology — Payments: $4,168
Gastroenterology $4,168
Dr. Gregory Gibson, M.d, M.D
Gastroenterology — Payments: $3,874
Gastroenterology $3,874
Glenn Hedgpeth, Md, MD
Gastroenterology — Payments: $1,069
Gastroenterology $1,069
Yucel Aydin, Md, MD
Gastroenterology — Payments: $352.11
Gastroenterology $352.11